Search research articles
Contact Us
Filters
Showing results (151-160 of 224) with videos related to
Page
of 23
Sort By:
European Journal of Pharmacology
|
May 23, 1998
WAY 100,635 enhances both the 'antidepressant' actions of duloxetine and its influence on dialysate levels of serotonin in frontal cortex
M J Millan, M Brocco, S Veiga, et al.
British Journal of Pharmacology
|
November 11, 1999
Changes in EEG spectral power in the prefrontal cortex of conscious rats elicited by drugs interacting with dopaminergic and noradrenergic transmission
C Sebban, X Q Zhang, B Tesolin-Decros, et al.
Brain Research
|
March 16, 1981
Stress-induced release of brain and pituitary beta-endorphin: major role of endorphins in generation of hyperthermia, not analgesia
M J Millan, R Przewłocki, M Jerlicz, et al.
Neuropharmacology
|
December 21, 2006
Dopamine D1 receptor coupling to Gs/olf and Gq in rat striatum and cortex: a scintillation proximity assay (SPA)/antibody-capture characterization of benzazepine agonists
C Mannoury la Cour, S Vidal, V Pasteau, et al.
European Journal of Pharmacology
|
November 24, 1994
Modulation of mesolimbic dopamine release by the selective dopamine D3 receptor antagonist, (+)-S 14297
J M Rivet, V Audinot, A Gobert, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 1993
Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists
M J Millan, J M Rivet, H Canton, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1994
5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm
M J Millan, J M Rivet, A Gobert, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 28, 2000
S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: II. Functional and behavioral profile compared with GR218,231 and L741,626
M J Millan, A Dekeyne, J M Rivet, et al.
Pharmacology, Biochemistry, and Behavior
|
March 13, 2002
Specific labelling of serotonin 5-HT(1B) receptors in rat frontal cortex with the novel, phenylpiperazine derivative, [3H]GR125,743. A pharmacological characterization
M J Millan, A Newman-Tancredi, S Lochon, et al.
European Journal of Pharmacology
|
October 15, 1991
S 14671: a novel naphthylpiperazine 5-HT1A agonist of high efficacy and exceptional in vivo potency
M J Millan, H Canton, J M Rivet, et al.
Page
of 23
Search research articles
Search
Showing results (151-160 of 224) with videos related to
Sort By:
Page
of 23
European Journal of Pharmacology
|
May 23, 1998
WAY 100,635 enhances both the 'antidepressant' actions of duloxetine and its influence on dialysate levels of serotonin in frontal cortex
M J Millan, M Brocco, S Veiga, et al.
British Journal of Pharmacology
|
November 11, 1999
Changes in EEG spectral power in the prefrontal cortex of conscious rats elicited by drugs interacting with dopaminergic and noradrenergic transmission
C Sebban, X Q Zhang, B Tesolin-Decros, et al.
Brain Research
|
March 16, 1981
Stress-induced release of brain and pituitary beta-endorphin: major role of endorphins in generation of hyperthermia, not analgesia
M J Millan, R Przewłocki, M Jerlicz, et al.
Neuropharmacology
|
December 21, 2006
Dopamine D1 receptor coupling to Gs/olf and Gq in rat striatum and cortex: a scintillation proximity assay (SPA)/antibody-capture characterization of benzazepine agonists
C Mannoury la Cour, S Vidal, V Pasteau, et al.
European Journal of Pharmacology
|
November 24, 1994
Modulation of mesolimbic dopamine release by the selective dopamine D3 receptor antagonist, (+)-S 14297
J M Rivet, V Audinot, A Gobert, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 1993
Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists
M J Millan, J M Rivet, H Canton, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1994
5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm
M J Millan, J M Rivet, A Gobert, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 28, 2000
S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: II. Functional and behavioral profile compared with GR218,231 and L741,626
M J Millan, A Dekeyne, J M Rivet, et al.
Pharmacology, Biochemistry, and Behavior
|
March 13, 2002
Specific labelling of serotonin 5-HT(1B) receptors in rat frontal cortex with the novel, phenylpiperazine derivative, [3H]GR125,743. A pharmacological characterization
M J Millan, A Newman-Tancredi, S Lochon, et al.
European Journal of Pharmacology
|
October 15, 1991
S 14671: a novel naphthylpiperazine 5-HT1A agonist of high efficacy and exceptional in vivo potency
M J Millan, H Canton, J M Rivet, et al.
Page
of 23